Rutgers cancer prevention expert calls for FDA action to reduce colon cancer and osteoporosis

July 22, 2004

NEW BRUNSWICK/PISCATAWAY, N.J. — Rutgers veteran cancer prevention expert Harold Newmark knows how to simultaneously achieve a 20 percent reduction in colon cancer deaths and osteoporosis-related fractures. Now he's calling upon the U.S. Food and Drug Administration (FDA) to help make this happen.

Newmark's call to action involves the simple addition of calcium and vitamin D to the existing FDA-mandated enrichment mix in products such as bread and pasta. He contends the measure could save 11,000 lives and an estimated $3 billion in U.S. health care costs annually. But it requires policy changes by the FDA that would need to be reflected in federal law.

In an article appearing in the Aug. 1 issue of the American Journal of Clinical Nutrition, Newmark and colleagues propose these nutrients be added to the current enrichment program for cereal-grain products. "The benefits would be a significant reduction in the incidences of osteoporosis and colon cancer over time and an overall improvement in health at a modest financial cost and with minor modification of existing technology," the paper concludes.

Newmark is an adjunct professor-in-residence at the Susan Lehman Cullman Laboratory for Cancer Research (Ernest Mario School of Pharmacy) of Rutgers, The State University of New Jersey. His coauthors are Paul Lachance of Rutgers, an authority on nutritional supplements, and Robert Heaney, an osteoporosis expert at Creighton University (Omaha).

Calcium's crucial role in bone replacement is understood, but its effect in the colon is less well known. In the presence of high-fat diets - seemingly part of the American way of life - calcium helps inactivate the resulting fatty acids in the colon that produce irritation, cell damage and other effects that can lead to cancer, Newmark says. Vitamin D aids in the absorption of dietary calcium by the body.

For decades, researchers have recognized the role of calcium in reducing the risk of diseases such as osteoporosis and colon cancer, but this has not been reflected in federal regulations. Newmark and his colleagues use their paper to illustrate the magnitude of the problem, explain the simplicity of the solution and underscore the urgency of making the needed policy changes.

U.S. Department of Agriculture surveys cited in the paper show that Americans consume seriously inadequate dietary calcium and vitamin D - far below the recommended levels established by the Food Nutrition Board, Institute of Medicine of the National Academy of Sciences. The Code of Federal Regulations (Title 21) requires the enrichment of certain cereal-derived food products with vitamins and minerals such as thiamine, riboflavin, niacin and iron, but calcium and vitamin D are optional and consequently ignored by producers, the authors contend.

"For about 10 cents per person per year, we can use existing technology to correct all this," Newmark says. "We believe that the time has come for a full scientific review of cereal-grain enrichment with calcium and vitamin D as a low-cost, safe and useful route for the reduction of osteoporosis and colon cancer in the United States in both men and women."
-end-
040722-2
Newmark Calcium.rev.ed

Rutgers University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.